Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 06 Apr 2021 |
2 | Journal Copy | 11 Jun 2021 |
3 | TM-O(NOTICE OF OPPOSITION) | 07 Sep 2021 |
4 | TM-O(NOTICE OF OPPOSITION) | 17 Sep 2021 |
5 | TM-O(NOTICE OF OPPOSITION) | 22 Sep 2021 |
6 | Annexure -1 under rule 46 | 07 Mar 2022 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 07 Mar 2022 |
7 | Annexure -1 under rule 46 | 07 Mar 2022 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 07 Mar 2022 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 15 Mar 2022 |
9 | Annexure -1 under rule 46 | 15 Mar 2022 |
1 | Opposition Notice | 12301395 | 5333562 | 12 Oct 2021 |
2 | Opposition Notice | 12392696 | 5354368 | 29 Oct 2021 |
3 | Opposition Counter Statement | 12521973 | 5381522 | 24 Nov 2021 |
4 | Opposition Counter Statement | 12583503 | 5396036 | 04 Dec 2021 |
5 | Generate Report | 12624879 | 5413600 | 10 Dec 2021 |
6 | Opposition Notice | 16105845 | 6225400 | 23 Sep 2023 |
7 | Opposition Counter Statement | 16732611 | 6372548 | 05 Dec 2023 |
The application for Molvir was made on 06 April 2021.
The trademark applicant for Molvir is SUN PHARMACEUTICAL INDUSTRIES.
Molvir is applied in class(es) 5.
Application for Molvir is on Opposed stage.
Application Id allotted to Molvir is 4935692.
Molvir filed with the Intellectual property office as a WORD.